In this webinar, we discuss methods to help you be successful in obtaining a prior authorization for diabetes medication and technology. You’ll learn how to apply workflow models that can be used by the diabetes care team to receive prior authorization for insulin, SGLT-2 inhibitors, GLP-1 receptor agonists, and diabetes technology for varying types of insurance. Panelists highlight payor considerations for Medicare, Medicaid and commercial health plans. Thank you to our webinar collaborators ASHP (American Society of Health-System Pharmacists) and ACOFP (American College of Osteopathic Family Physicians).

• Identify methods to be successful in obtaining a Prior Authorization for diabetes medication and technology 
• Apply workflow models that can be used by the diabetes care team to receive prior authorization for insulin, SGLT-2, GLP-1, and diabetes technology for varying types of insurance